In the early phase of the coronavirus pandemic, several hundred Dutch people died from the side effects of hydroxychloroquine, the malaria drug that seemed promising against COVID-19.
Preparations are underway in the Netherlands for an extensive European study aimed at determining whether existing, readily available, and affordable medications can alleviate symptoms in long Covid patients, NOS reported on Friday. The research will initially focus on commonly used and inexpensive drugs, including those for diabetes.